Ireland shielded from new US pharmaceutical tariffs under EU deal

Ireland’s €33bn pharmaceutical exports to the US remain protected under the EU-US trade deal, despite Trump’s newly announced 100% tariffs

Ireland is a major supplier of pharmaceuticals to the US, exporting €33bn worth of products last year.

New US tariffs targeting pharmaceuticals do not apply to countries that have already negotiated trade deals with the Trump administration, the White House has confirmed.

President Trump announced on Friday a suite of new tariff measures, including 100% duties on pharmaceuticals set to take effect on October 1, casting uncertainty over a previous framework agreement between the EU and the US.